Abstract:Nanocarriers, more commonly called nanoparticles (NPs), have found increasing use as delivery vehicles which increase the oral bioavailability of poorly water-soluble and peptide therapeutics. Therapeutic bioavailability is commonly assessed by measuring plasma concentrations that reflect the absorption kinetics. This bioavailability is a convolution of the gastrointestinal distribution of the NP vehicle, the release rate of the encapsulated therapeutic cargo, and the absorption-metabolism-distribution kinetics of the released therapeutic. The spatiotemporal distribution of the NP vehicle in the gastrointestinal tract is not well studied and is a buried parameter in PK studies used to measure the effectiveness of an NP formulation. This work is a study of the intestinal distribution and fate of orally dosed NPs in male CD-1 mice over 24 h. NPs have identical hydrophobic cores - composed of poly(styrene) homopolymer, a naphthalocyanine dye, and oleate-coated europium oxide colloids - with one of four different surface stabilizers: neutral poly(styrene)-block-poly(ethylene glycol) (PS-b-PEG), moderately negative hydroxypropyl methylcellulose acetate succinate (HPMCAS), highly negative poly(styrene)-block-poly(acrylic acid) (PS-b-PAA), and highly cationic adsorbed chitosan HCl on PS-b-PAA stabilized NPs. NP hydrodynamic diameters are all below 200 nm, with some variation attributable to the molecular properties of the stabilizing polymer. The encapsulated hydrophobic europium oxide colloids do not release soluble europium ions, enabling the use of highly sensitive inductively coupled plasma mass spectrometry (ICP-MS) to detect NP concentrations in digested biological tissues. Highly anionically-charged PAA and cationically-charged chitosan stabilized NPs showed statistically significant increased retention compared to the neutral PEG-stabilized NPs at p < 0.05 significance and (1-β) > 0.95 power. HPMCAS-stabilized NPs showed statistically insignificant greater retention than PEG-stabilized NPs, and all NP formulations showed clearance from the intestines within 24 h. Different surface charges preferentially reside in different segments of the intestines, where cationic chitosan-stabilized NPs showed increased retention in the small intestines (ileum) and anionic PAA-stabilized NPs in the large intestines (caecum and colon). Modifying the surface charge of a NP can be used to modulate mucoadhesion, total retention, and intestinal segment specific retention, which enables the rational design of delivery vehicles that maximize residence times in appropriate locations.

Research of Isolated Intestina Parva Absorption of Lipid Nanoparticles in Rats

Size-dependent Placental Retention Effect of Liposomes in ICR Pregnant Mice: Potential Superiority in Placenta-Derived Disease Therapy

Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics

In vitro evaluation and in situ intestinal absorption characterisation of paeoniflorin nanoparticles in a rat model

Effect of Surface Charges on Oral Absorption of Intact Solid Lipid Nanoparticles

Intestinal distribution of anionic, cationic, and neutral polymer-stabilized nanocarriers measured with a lanthanide (europium) tracer assay

Evidence Does Not Support Absorption of Intact Solid Lipid Nanoparticles Via Oral Delivery.

Size-dependent Absorption Mechanism of Polymeric Nanoparticles for Oral Delivery of Protein Drugs

Enhanced Oral Absorption and Liver Distribution of Polymeric Nanoparticles Through Traveling the Enterohepatic Circulation Pathways of Bile Acid

Studies on Oral Absorption of Stearic Acid SLN by a Novel Fluorometric Method

Physicochemical and In Vitro Digestion Properties of Curcumin-Loaded Solid Lipid Nanoparticles with Different Solid Lipids and Emulsifiers

Functional lipid polymeric nanoparticles for oral drug delivery: Rapid mucus penetration and improved cell entry and cellular transport

Distribution, Transition, Adhesion and Release of Insulin Loaded Nanoparticles in the Gut of Rats.

Preparation and Characterization of Liposomes Encapsulating Chitosan Nanoparticles

Insight into the in vivo translocation of oral liposomes by fluorescence resonance energy transfer effect

Studies on Insulin-Loaded Stearylamine Nanoparticles:Preparation and Physicochemical Properties

Size-Dependent Biodistribution of Lodinated Oil Nanoemulsions Observed by Dual-Modal Imaging in Rats.

Zein-casein-lysine multicomposite nanoparticles are effective in modulate the intestinal permeability of ferulic acid

Histological findings for the absorption of small and large liposomes – the basis of future drug delivery and contrast media systems

Improved Transport and Absorption Through Gastrointestinal Tract by PEGylated Solid Lipid Nanoparticles

Formulation and Intestinal Absorption of Naringenin Loaded Nanostructured Lipid Carrier and Its Inhibitory Effects on Nonalcoholic Fatty Liver Disease.